Meda Ab (MDABY) 17.9000 $MDABY MEDA: Notice to

New Post Public Reply Private Reply Replies (0) Message Board

Aug 21, 2016 at 5:05 PM

Meda Ab (MDABY) 17.9000 $MDABY

MEDA: Notice to noteholders regarding change of control
BusinessWire - Fri Aug 05, 10:06AM CDT
Regulatory News:

Meda Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting
BusinessWire - Tue Aug 02, 10:23AM CDT
Regulatory News:

Extraordinary General Meeting of Meda Aktiebolag (publ)
BusinessWire - Tue Aug 02, 10:10AM CDT
Regulatory News:

Mylan Announces Pricing of Senior Notes
PR Newswire - Tue May 31, 4:24PM CDT
Mylan N.V. (NASDAQ, TASE: MYL) today announced the pricing of a private placement of $6.5 billion aggregate principal amount of senior notes, comprised of $1.0 billion aggregate principal amount of 2.50% senior notes due 2019 at an issue price of 99.888%, $2.25 billion aggregate principal amount of 3.15% senior notes due 2021 at an issue price of 99.884%, $2.25 billion aggregate principal amount of 3.95% senior notes due 2026 at an issue price of 99.231% and $1.0 billion aggregate principal amount of 5.25% senior notes due 2046 at an issue price of 99.984%. Mylan intends to use the net proceeds from the offering of notes to finance its previously announced public offer (the "Offer"

to acquire all of the outstanding shares of Meda AB (publ.) (the "Meda Acquisition"

, to repay, prepay, redeem or otherwise refinance its or any of its subsidiaries' indebtedness (including that of Meda and its subsidiaries) (the "Refinancing"

and to pay costs associated with the Meda Acquisition and the Refinancing, including non-periodic fees, costs and expenses, stamp registration and other taxes. Upon completion of the offering of the notes, Mylan intends to reduce the commitments under its Bridge Credit Agreement, dated as of Feb. 10, 2016, in an amount equal to the aggregate net proceeds from the offering of the notes. Subject to customary closing conditions, the sale of the notes is expected to close on or about June 9, 2016.
MYL: 48.66 (-0.66)

MEDA: Interim Report, January-March 2016
BusinessWire - Tue May 03, 1:18AM CDT
Regulatory News:

MEDA: Invitation to teleconference for analysts, investors and media
BusinessWire - Tue Apr 26, 6:12AM CDT
Regulatory News:

Meda AB (publ) AGM bulletin
BusinessWire - Thu Apr 14, 2:15PM CDT
Regulatory News:

Business Highlights
By The Associated Press - AP - Wed Feb 10, 5:45PM CST
___
WFM: 30.28 (+0.07), BUD: 126.38 (-0.43), TGT: 70.12 (-0.18), WMT: 72.81 (-1.49), ODP: 3.52 (-0.02)

Statement by the Board of Directors of Meda in relation to the public offer by Mylan
BusinessWire - Wed Feb 10, 5:29PM CST
Regulatory News:

Mylan to buy Sweden's Meda AB for $7.2 billion
AP - Wed Feb 10, 4:42PM CST
NEW YORK (AP) — Drugmaker Mylan says it will buy Meda AB of Sweden for $7.2 billion in cash and stock, and says the move will help it enter new markets.
ABT: 44.24 (-0.12), MYL: 48.66 (-0.66)

MEDA: Year-end Report, January-December 2015
BusinessWire - Wed Feb 10, 4:09PM CST
Regulatory News:

MEDA: Invitation to Teleconference for Analysts, Investors and Media
BusinessWire - Thu Feb 04, 4:47AM CST
Meda AB (STO:MEDAA) (Pink Sheets:MDABY)

MEDA completes divestment of Euromed manufacturing unit in Spain
M2 - Thu Dec 31, 5:21AM CST
Meda AB (STO:MEDAA) (Pink Sheets:MDABY) on Wednesday announced the completion of the divestment of its manufacturing unit Euromed in Spain.

MEDA: Divestment of Manufacturing Unit Euromed in Spain Completed
BusinessWire - Wed Dec 30, 1:09AM CST
Regulatory News:

Muscle Spasm Global Clinical Trials Review, H2, 2015 - Analysis & Technologies
M2 - Mon Dec 14, 5:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/gsz2s9/muscle_spasm) has announced the addition of the "Muscle Spasm Global Clinical Trials Review, H2, 2015" report to their offering. This clinical trial report, Muscle Spasm Global Clinical Trials Review, H2, 2015" provides an overview of Muscle Spasm clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Spasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Key Topics Covered: - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Benefits of this Report: - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level Companies Mentioned: - Themis Medicare Ltd. - Inventia Healthcare Private Limited - Allergan Plc - Flex Pharma, Inc. - Navipharm Co., Ltd - Meda AB - Ipsen S.A. - Eisai Co., Ltd. - Dr. Reddy's Laboratories Limited - Avigen, Inc. For more information visit http://www.researchandmarkets.com/research/gs...scle_spasm
AGN: 253.14 (+0.21), FLKS: 11.44 (-0.01)

Update on License Agreement between Meda and Valeant
BusinessWire - Mon Nov 16, 12:12AM CST
Regulatory News:

Meda reports profit after tax of SEK163m in Q3 2015
M2 - Fri Nov 06, 3:33AM CST
Meda AB (STO:MEDAA) (Pink Sheets:MDABY) on Thursday reported profit after tax of SEK163m, or EPS of SEK0.45, for the third quarter of 2015, from July 2015 to September 2015.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

China Southern Airlines Marks 70th Anniversary in NYC

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

AST SpaceMobile Faces Class Action Over Misstatements

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

HONA Faces Legal Heat: Investor Lawsuit Over Losses

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Cut Winter Heating Costs with Townsend's Rebate Help

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Timur Turlov Leads FIDE with Chess and Digital Focus

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Farm Aid 2026: A Resilient Tribute to Family Farmers

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

AI and Storytelling Make Waves in Science Education

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...